Evidence map›Paper›PMID 20033348›Full record

ArticleObesity surgery2010

SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis.

Cíntia dos Santos Costa, Thais Ortiz Hammes, Francieli Rohden, Rogério Margis, Josiane Woutheres Bortolotto, Alexandre Vontobel Padoin, Cláudio Cora Mottin, Regina Maria Guaragna

Open access · greenAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Role of microRNA-22 in Metabolism.International journal of molecular sciences · 2025
    Review
  7. The Molecular Basis of Male Infertility in Obesity: A Literature Review.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Genetic Variants ofInternational journal of endocrinology · 2023
    Article
  11. Review
  12. Evaluation of Rosuvastatin Therapy onCurrent therapeutic research, clinical and experimental · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. The effect ofIranian journal of basic medical sciences · 2021
    Review
  18. Article
  19. Cinnamon as Dietary Supplement Caused Hyperlipidemia in Healthy Rats.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  20. A Molecular Perspective on Sirtuin Activity.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Cíntia dos Santos CostaDepartamento de Bioquímica, ICBS, UFRGS, Rua Ramiro Barcelos 2600-anexo, 90035-003 Porto Alegre, Rio Grande do Sul, Brazil.
Thais Ortiz Hammes
Francieli Rohden
Rogério Margis
Josiane Woutheres Bortolotto
Alexandre Vontobel Padoin
Cláudio Cora Mottin
Regina Maria Guaragna
Universidade Federal do Rio Grande do Sul · BRHospital São Lucas da PUCRS · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVisceral adipose tissue is known to release greater amounts of adipokines and free fatty acids into the portal vein, being one of the most predictive factors of nonalcoholic fatty liver disease (NAFLD). Our study has the purpose to evaluate sirtuin 1 (SIRT1), adiponectin, Forkhead/winged helix (FOXO1), peroxisome proliferator-activated receptor (PPAR)gamma1-3, and PPARbeta/delta mRNA expression in morbidly obese patients in three different lipid depots: visceral (VAT), subcutaneous (SAT), and retroperitoneal (RAT). Recent studies suggest that SIRT1, a NAD(+)-dependent deacetylase, protects rats from NAFLD.

methodsWe divided the patients in two groups: those with slight or moderate steatosis (hepatic steatosis, HS) and other comprising individuals with severe steatosis associated or not with necroinflammation and fibrosis (severe hepatic steatosis, SHS). The adipose tissue depots were obtained during bariatric surgery. Total RNAs were extracted using TRIzol. The amount of genes of interest was determined by quantitative real-time polymerase chain reaction.

resultsWhen comparing the two groups of patients, a decrease in SIRT1 was observed in VAT of morbidly obese patients in SHS group (p = 0.006). The mRNA expression of the other genes showed no differences in VAT. No difference was found either in SAT or in RAT for all genes in the study. In addition, the homeostasis model assessment for insulin resistance (HOMA-IR) value was higher in SHS group compared to HS (p = 0.006). Also, our results show that the mRNA expression of SIRT1 and the value of HOMA-IR were positively correlated in VAT of SHS patients (r = 0.654; p = 0.048).

conclusionsDownregulation of SIRT1 mRNA expression in VAT of SHS could be possible impairing mitochondria biogenesis and fatty acid oxidation, promoting severe steatosis in obese patients. Our results provide a possible proof of SIRT1 protective potential in VAT against NAFLD in humans.

Indexed as

Fatty LiverGastric BypassGene ExpressionHumansIntra-Abdominal FatObesity, MorbidSirtuin 1Subcutaneous FatTranscription, GeneticTreatment OutcomeSIRT1 protein, humanSirtuin 1

Identifiers

PMID20033348
OpenAlexW2041983801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.